Event Brief
Jan 9, 2026 at 12:03 AM ET
Merck in Talks to Acquire Revolution Medicines for $32bn
By The BriefBrief
Merck aims to buy Revolution Medicines, known for its pancreatic cancer treatment.
WHO: Merck
WHAT: Acquisition talks
WHEN: Jan 8, 2026 at 7:00 PM ET
WHERE: United States
WHY: To enhance cancer treatment portfolio
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Amazon faces months of repairs after drone strikes
Amazon
May 1, 2026 at 3:23 PM ET
Minnesota bans fake AI nudes; app makers face $500K
Minnesota
May 1, 2026 at 3:23 PM ET
Page 21432 of 21432
Same format. Every time.
Continue reading — sign in or create a free account with
